Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

While compounded medications like this use ingredients that are Food and Drug Administration (FDA) approved in other medications, this specific product isn’t FDA approved. Cialis, the brand name ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Read on to find out more ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

A drug used to prevent organ rejection in kidney transplant patients is being touted for potentially slowing down aging. The immune-suppressing medication rapamycin, also known as sirolimus ...

State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.

Regardless of where you live in the U.S., chances are you stand in the grocery aisle, price-comparing generic items to name brand ones. You’re not alone, either. Private-label brand sales ...